Witzig TE - Search Results

1

Ghobrial IM, Witzig TE. Ghobrial IM, et al. Among authors: witzig te. Curr Treat Options Oncol. 2004 Jun;5(3):239-47. doi: 10.1007/s11864-004-0015-5. Curr Treat Options Oncol. 2004. PMID: 15115652 Free PMC article. Review.

2

Role of plasmapheresis in thrombocytopenic purpura associated with Waldenström's macroglobulinemia.

Patel TC, Moore SB, Pineda AA, Witzig TE. Patel TC, et al. Among authors: witzig te. Mayo Clin Proc. 1996 Jun;71(6):597-600. doi: 10.4065/71.6.597. Mayo Clin Proc. 1996. PMID: 8642891 Review.

3

Biology and treatment of myeloma.

Greipp PR, Witzig T. Greipp PR, et al. Curr Opin Oncol. 1996 Jan;8(1):20-7. doi: 10.1097/00001622-199601000-00004. Curr Opin Oncol. 1996. PMID: 8868095 Review.

4

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.

Witzig TE, White CA, Wiseman GA, Gordon LI, Emmanouilides C, Raubitschek A, Janakiraman N, Gutheil J, Schilder RJ, Spies S, Silverman DH, Parker E, Grillo-López AJ. Witzig TE, et al. J Clin Oncol. 1999 Dec;17(12):3793-803. doi: 10.1200/JCO.1999.17.12.3793. J Clin Oncol. 1999. PMID: 10577851 Clinical Trial.

5

Waldenström's macroglobulinaemia: a prospective study comparing daily with intermittent oral chlorambucil.

Kyle RA, Greipp PR, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Therneau TM. Kyle RA, et al. Among authors: witzig te. Br J Haematol. 2000 Mar;108(4):737-42. doi: 10.1046/j.1365-2141.2000.01918.x. Br J Haematol. 2000. PMID: 10792277 Free article. Clinical Trial.

6

The use of ibritumomab tiuxetan radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphoma.

Witzig TE. Witzig TE. Semin Oncol. 2000 Dec;27(6 Suppl 12):74-8. Semin Oncol. 2000. PMID: 11226003

7

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

Wiseman GA, White CA, Sparks RB, Erwin WD, Podoloff DA, Lamonica D, Bartlett NL, Parker JA, Dunn WL, Spies SM, Belanger R, Witzig TE, Leigh BR. Wiseman GA, et al. Among authors: witzig te. Crit Rev Oncol Hematol. 2001 Jul-Aug;39(1-2):181-94. doi: 10.1016/s1040-8428(01)00107-x. Crit Rev Oncol Hematol. 2001. PMID: 11418315 Clinical Trial.

8

Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma.

Witzig TE. Witzig TE. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S91-5. doi: 10.1007/s002800100312. Cancer Chemother Pharmacol. 2001. PMID: 11587375 Review.

9

Phase 1 study of interleukin-12 in combination with rituximab in patients with B-cell non-Hodgkin lymphoma.

Ansell SM, Witzig TE, Kurtin PJ, Sloan JA, Jelinek DF, Howell KG, Markovic SN, Habermann TM, Klee GG, Atherton PJ, Erlichman C. Ansell SM, et al. Among authors: witzig te. Blood. 2002 Jan 1;99(1):67-74. doi: 10.1182/blood.v99.1.67. Blood. 2002. PMID: 11756154 Free article. Clinical Trial.

10

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.

Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA, Greipp PR, Rajkumar SV, Gertz MA, Lust JA, Lacy MQ, Dispenzieri A, Witzig TE, Fonseca R. Schop RF, et al. Among authors: witzig te. Cancer Genet Cytogenet. 2002 Jan 1;132(1):55-60. doi: 10.1016/s0165-4608(01)00526-x. Cancer Genet Cytogenet. 2002. PMID: 11801310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters